Small-molecule screening using a whole-cell viral replication reporter gene assay identifies 2-{[2-(benzoylamino)benzoyl]amino}-benzoic acid as a novel antiadenoviral compound

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3871-3877

  Andersson, Emma K ^a   Strand, Mårten ^a   Edlund, Karin ^a   Lindman, Kristina ^a   Enquist, Per Anders ^a   Spjut, Sara ^a   Allard, Annika ^a   Elofsson, Mikael ^a   Mei, Ya Fang ^a   Wadell, Göran ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 (BENZOYLAMINO)BENZOYL]AMINO]BENZOIC ACID; ANTIVIRUS AGENT; GREEN FLUORESCENT PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXPRESSION VECTOR; FLUORESCENCE; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; VIRUS INHIBITION; VIRUS REPLICATION; WHOLE CELL;

ADENOVIRIDAE; ANTIVIRAL AGENTS; BENZOIC ACID; CELL LINE, TUMOR; FLOW CYTOMETRY; GENES, REPORTER; HUMANS; POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 77956097757     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00203-10     Document Type: Article

References (42)

1. Adrian, T. H., G. Wadell, J. C. Hierholzer, and R. Wigand. 1986. DNA restriction patterns of adenovirus prototypes 1 to 41. Arch. Virol. 91:277-299.
2. Allard, A., B. Albinsson, and G. Wadell. 2001. Rapid typing of human adenoviruses by a general PCR combined with restriction endonuclease analysis. J. Clin. Microbiol. 39:498-505.
3. Baba, M., S. Mori, S. Shigeta, and E. De Clercq. 1987. Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2′-norcyclic GMP on adenovirus replication in vitro. Antimicrob. Agents Chemother. 31:337-339.
4. Baldwin, A., H. Kingman, M. Darville, A. B. M. Foot, D. Grier, J. M. Cornish, N. Goulden, A. Oakhill, D. H. Pamphilon, C. G. Steward, and D. I. Marks. 2000. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant. 26:1333-1338.
5. Bordigoni, P., A.-S. Carret, V. Venard, F. Witz, and A. Le Faou. 2001. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 32:1290-1297.
6. Carmichael, J., W. G. DeGraff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47:936-942.
7. Chen, F. E., R. H. S. Liang, J. Y. Lo, K. Y. Yuen, T. K. Chan, and M. Peiris. 1997. Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir. Bone Marrow Transplant. 20:997-999. (Pubitemid 27510966)
8. De Jong, J. C., A. G. Wermenbol, M. W. Verweij-Uijterwaal, K. W. Slaterus, P. Wertheim-Van Dillen, G. J. Van Doornum, S. H. Khoo, and J. C. Hierholzer. 1999. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J. Clin. Microbiol. 37:3940-3945.
9. Denizot, F., and R. Lang. 1986. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89:271-277. (Pubitemid 16080782)
10. de Oliveira, C. B. R., D. Stevenson, L. LaBree, P. J. McDonnell, and M. D. Trousdale. 1996. Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antivir. Res. 31:165-172.
11. Diaconu, I., V. Cerullo, S. Escutenaire, A. Kanerva, G. J. Bauerschmitz, R. Hernandez-Alcoceba, S. Pesonen, and A. Hemminki. 2010. Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir. J. Gene Med. 12:435-445.
12. Gavin, P. J., and B. Z. Katz. 2002. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 110:e9.
13. Hartline, C. B., K. M. Gustin, W. B. Wan, S. L. Ciesla, J. R. Beadle, K. Y. Hostetler, and E. R. Kern. 2005. Ether lipid ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro. J. Infect. Dis. 191:396-399.
14. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real-time quantitative PCR. Genome Res. 6:986-994.
15. Hernroth, B. E., A. C. Conden-Hansson, A. S. Rehnstam-Holm, R. Girones, and A. K. Allard. 2002. Environmental factors influencing human viral pathogens and their potential indicator organisms in the blue mussel, Mytilus edulis: the first Scandinavian report. Appl. Environ. Microbiol. 68:4523-4533.
16. Hierholzer, J. C. 1992. Adenoviruses in the immunocompromised host. Clin. Microbiol. Rev. 5:262-274.
17. Hoffman, J. A., A. J. Shah, L. A. Ross, and N. Kapoor. 2001. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 7:388-394.
18. Howard, D. S., G. L. Phillips Ii, D. E. Reece, R. K. Munn, J. Henslee- Downey, M. Pittard, M. Barker, and C. Pomeroy. 1999. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 29:1494-1501.
19. Izzedine, H., V. Launay-Vacher, and G. Deray. 2005. Antiviral drug-induced nephrotoxicity. Am. J. Kidney Dis. 45:804-817.
20. Janner, D., A. M. Petru, D. Belchis, and P. H. Azimi. 1990. Fatal adenovirus infection in a child with acquired immunodeficiency syndrome. Pediatr. Infect. Dis. J. 9:434-436.
21. Klinger, J. R., M. P. Sanchez, L. A. Curtin, M. Durkin, and B. Matyas. 1998. Multiple cases of life-threatening adenovirus pneumonia in a mental health care center. Am. J. Respir. Crit. Care Med. 157:645-649.
22. Kojaoghlanian, T., P. Flomenberg, and M. S. Horwitz. 2003. The impact of adenovirus infection on the immunocompromised host. Rev. Med. Virol. 13:155-171.
23. Kroes, A. C. M., E. P. A. de Klerk, A. C. Lankester, C. Malipaard, C. S. de Brouwer, E. C. J. Claas, E. C. Jol-van der Zijde, and M. J. D. van Tol. 2007. Sequential emergence of multiple adenovirus serotypes after pediatric stem cell transplantation. J. Clin. Virol. 38:341-347.
24. Lankester, A. C., B. Heemskerk, E. C. J. Claas, M. W. Schilham, M. F. C. Beersma, R. G. M. Bredius, M. J. D. van Tol, and A. C. M. Kroes. 2004. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin. Infect. Dis. 38:1521-1525.
25. Lee, C. K., and Y. M. Ahn. 1989. Reactions of amides with potassium permanganate in neutral aqueous solution. J. Organic Chem. 54:3744-3747.
26. Leruez-Ville, M., M. Chardin-Ouachee, B. Neven, C. Picard, I. Le Guinche, A. Fischer, C. Rouzioux, and S. Blanche. 2006. Description of an adenovirus A31 outbreak in a paediatric haematology unit. Bone Marrow Transplant. 38:23-28. (Pubitemid 43923085)
27. Mei, Y.-F., K. Lindman, and G. Wadell. 1998. Two closely related adenovirus genome types with kidney or respiratory tract tropism differ in their binding to epithelial cells of various origins. Virology 240:254-266.
28. Meier, P., S. Dautheville-Guibal, P. M. Ronco, and J. Rossert. 2002. Cidofovir-induced end-stage renal failure. Nephrol. Dial. Transplant. 17:148-149.
29. Michaels, M. G., M. Green, E. R. Wald, and T. E. Starzl. 1992. Adenovirus infection in pediatric liver transplant recipients. J. Infect. Dis. 165:170-172.
30. Morfin, F., S. Dupuis-Girod, S. Mundweiler, D. Falcon, D. Carrington, P. Sedlacek, M. Bierings, P. Cetkovsky, A. C. M. Kroes, M. J. D. van Tol, and D. Thouvenot. 2005. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antiviral Ther. 10:225-229.
31. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63. (Pubitemid 14203433)
32. Muller, W. J., M. J. Levin, Y. K. Shin, C. Robinson, R. Quinones, J. Malcolm, E. Hild, D. Gao, and R. Giller. 2005. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 41:1812-1816.
33. Naesens, L., L. Lenaerts, G. Andrei, R. Snoeck, D. Van Beers, A. Holy, J. Balzarini, and E. De Clercq. 2005. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob. Agents Chemother. 49:1010-1016.
34. Roehm, N. W., G. H. Rodgers, S. M. Hatfield, and A. L. Glasebrook. 1991. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods 142:257-265.
35. Sandberg, L., P. Papareddy, J. Silver, A. Bergh, and Y.-F. Mei. 2009. Replication-competent Ad11p vector (RCAd11p) efficiently transduces and replicates in hormone-refractory metastatic prostate cancer cells. Hum. Gene Ther. 20:361-373.
36. Scudiero, D. A., R. H. Shoemaker, K. D. Paull, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, and M. R. Boyd. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827-4833.
37. Segerman, A., N. Arnberg, A. Erikson, K. Lindman, and G. Wadell. 2003. There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses. J. Virol. 77:1157-1162. (Pubitemid 36055538)
38. Toth, K., J. F. Spencer, D. Dhar, J. E. Sagartz, R. M. L. Buller, G. R. Painter, and W. S. M. Wold. 2008. Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. Proc. Natl. Acad. Sci. 105:7293-7297.
39. Wadell, G. 1984. Molecular epidemiology of human adenoviruses. Curr. Topics Microbiol. Immunol. 110:191-220.
40. Wadell, G., A. Allard, and J. C. Hierholzer. 1999. Adenoviruses, p. 970-982. In P. R. Murray, E. J. Baron, M. A. Pfaller, Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, DC.
41. Weislow, O. S., R. Kiser, D. L. Fine, J. Bader, R. H. Shoemaker, and M. R. Boyd. 1989. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J. Natl. Cancer Inst. 81:577-586.
42. Zedtwitz-Liebenstein, K., E. Presterl, E. Deviatko, and W. Graninger. 2001. Acute renal failure in a lung transplant patient after therapy with cidofovir. Transplant Int. 14:445-446. (Pubitemid 34000799)